Deal Watch: Genentech Gets Down In The Dirt With Lodo Therapeutics

11 May 2018

• By Joseph Haas, Brian Yang, and Jung Won Shin

Genentech and Lodo will mine the soil microbiome to discover novel therapeutics. China’s Luye licenses commercial rights to AstraZeneca’s Seroquel franchise, while Sarepta picked up rights to gene therapy candidates from Myonexus, plus an option to acquire the company.

Deal Watch: Genentech Gets Down In The Dirt With Lodo Therapeutics

More from Deals

More from Business